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background:  The ProMRI Study is a multicenter prospective, single arm, non-randomized study to evaluate the clinical safety of the 
Biotronik ProMRI Pacemaker System in patients (Pts) undergoing cardiac or thoracic spine 1.5T MRI scanning.
Methods:  Pts with an Entovis (DR-T or SR-T) and Setrox 53cm or 60cm lead(s) were eligible for enrollment > 5 weeks after pacemaker 
implant. Study defined, non-diagnostic, cardiac or thoracic spine MRI was performed at least 1 week after enrollment. Devices were placed 
in MRI pacing modes prior to scan and restored to non-MRI mode after scan. Interrogation was performed pre and post-MRI, and 1 month 
post-MRI. Primary endpoints were the percentage of Pts with freedom from 1) atrial and ventricular MRI induced pacing threshold increase 
≥ 0.5 Volts (V) from pre-MRI to 1 month post-MRI, 2) P and R wave amplitude decrease ≤ 50% from pre-MRI to 1 month post-MRI, and 3) 
MRI and pacing system related Serious Adverse Device Effects (SADE) through 1 month post-MRI.
results:  244 Pts were enrolled at 31 centers. 203 Pts underwent MRI scan. 199 Pts completed MRI scan and 1 month post-MRI follow-
up. 203 Pts were included in the intention to treat analyses. One adverse event was adjudicated as possibly related to both the MRI and 
implanted system, an episode of pericarditis 5wks post scan.
1 MONTH POST-MRI
COMPARED TO PRE-MRI P value
FREEDOM FROM ATRIAL PACING THRESHOLD INCREASE ≥ 0.5 V 100%(178/178 PTS) P< 0.001
FREEDOM FROM VENTRICULAR PACING THRESHOLD INCREASE ≥ 0.5 V 100%(189/189 PTS) P< 0.001
FREEDOM FROM P WAVE AMPLITUDE DECREASE ≤ 50% 98.1%(154/157 PTS) P< 0.001
FREEDOM FROM R WAVE AMPLITUDE DECREASE ≤ 50% 100%(173/173 PTS) P< 0.001
FREEDOM FROM SERIOUS ADVERSE DEVICE EFFECTS 99.5%(202/203 PTS) P< 0.001
Conclusion:  The results of the ProMRI study demonstrate the clinical safety and efficacy of the ProMRI Pacemaker System in patients 
undergoing cardiac or thoracic spine 1.5T MRI scanning without an exclusion zone.
